InsiderSignal.AI

InsiderSignal.ai

AXSM - Axsome Therapeutics, Inc.

Insider Purchase by Coleman Mark (Dir)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Coleman Mark, serving as Dir at Axsome Therapeutics, Inc. (AXSM), purchased 1,575 shares at $127.28 per share, for a total transaction value of $200,466.00. Following this transaction, Coleman Mark now holds 452,068 shares of AXSM.

The trade was executed on Monday, September 8, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 9, 2025, 1 day after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Coleman Mark

Dir

Mark Coleman, MD is a seasoned healthcare executive and board director, currently serving as Director at Axsome Therapeutics, Inc. (NASDAQ: AXSM) since December 2014.[[1]](https://matrixbcg.com/blogs/owners/axsome)[[2]](https://www.aimasterclass.com/person/mark-coleman)[[8]](https://www.axsome.com/about-axsome/board-of-directors/) He was an early advisor during the company's formation in 2012 and has contributed to its strategic governance as part of the board overseeing CNS disorder-focused biopharmaceutical development.[[1]](https://matrixbcg.com/blogs/owners/axsome)[[5]](https://firstwordpharma.com/story/5203995)[[8]](https://www.axsome.com/about-axsome/board-of-directors/) Dr. Coleman holds leadership roles including Director of Clinical Operations at National Spine & Pain Centers since February 2023, with prior positions such as Managing Partner & Medical Director at its Pikesville Office and President of Clinical Operations.[[2]](https://www.aimasterclass.com/person/mark-coleman) He also serves on the Board of Directors at Enalare Therapeutics Inc. since January 2021.[[2]](https://www.aimasterclass.com/person/mark-coleman)[[6]](https://theorg.com/org/enalare-therapeutics/org-chart/mark-coleman) As an Axsome insider, he recently purchased 1,575 shares on September 8, 2025, for $200,466, owning 48,212 shares directly and 403,856 indirectly, with total holdings valued at approximately $48 million as of May 2025.[[3]](https://www.investing.com/news/insider-trading-news/axsome-therapeutics-director-coleman-buys-200k-in-shares-93CH-4232509)[[4]](https://www.gurufocus.com/insider/33471/mark-coleman) Dr. Coleman is a graduate whose expertise spans clinical operations and pharmaceutical advisory.[[6]](https://theorg.com/org/enalare-therapeutics/org-chart/mark-coleman)[[7]](https://www.salary.com/research/executive-compensation/mark-coleman-m-d-board-member-of-axsome-therapeutics-inc)

View full insider profile →

Trade Price

$127.28

Quantity

1,575

Total Value

$200,466.00

Shares Owned

452,068

Trade Date

Monday, September 8, 2025

167 days ago

SEC Filing Date

Tuesday, September 9, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Axsome Therapeutics, Inc.

Company Overview

No company information available
View news mentioning AXSM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/264820

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime